InsidersTradesSigma
Follow the Fisher & Paykel Healthcare Corporation Limited share price and the full management transaction log of the company, a listed issuer based in Australia. Shares trade on the AU market, under the authority of ASX. Operating in the Health Care sector, Fisher & Paykel Healthcare Corporation Limited has published 1 insider filings. Market capitalisation: €21bn. The latest transaction was disclosed on 18 May 2026 (Initial Substantial Holding). Every trade is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Fisher & Paykel Healthcare Corporation Limited Buy (bullish), based on 9 analysts. Average price target: A$36.92.
Fundamental score
Ranked 8,750 of 29,057 companies
61.4
score / 100
Value37
Quality86
FCF yld2.2%
Earn yld2.2%
EV/EBITDA27.0x
ROE23%
Gross mgn64%
Net mgn20%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 May 2026
About Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited is a New Zealand company that specializes in the design and manufacture of medical devices for respiratory and anesthesia applications. It is listed on the XASX market.